Constellation Investments’s Allergan plc AGN Stock Holding History

Constellation Investments’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$2.37M	Buy	8,840 +200	+2%	+$57.3K	0.43%	54
2015 Q4	$2.7M	Buy	8,640 +200	+2%	+$59.5K	0.51%	44
2015 Q3	$2.29M	Hold	8,440	–	–	0.47%	48
2015 Q2	$2.56M	Buy	8,440 +200	+2%	+$59.7K	0.49%	45
2015 Q1	$2.45M	Buy	8,240 +2,820	+52%	+$804K	0.47%	48
2014 Q4	$1.4M	Buy	5,420 +300	+6%	+$75K	0.28%	80
2014 Q3	$1.24M	Buy	5,120 +1,820	+55%	+$407K	0.27%	81
2014 Q2	$736K	Hold	3,300	–	–	0.17%	139
2014 Q1	$679K	Buy	3,300 +100	+3%	+$19.8K	0.17%	143
2013 Q4	$538K	Buy	3,200 +300	+10%	+$46.9K	0.14%	174
2013 Q3	$418K	Buy	2,900 +900	+45%	+$120K	0.13%	187
2013 Q2	$252K	Buy	+2,000	New	+$226K	0.09%	266

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Constellation Investments's AGN Position: Q1 2016 in Review

Constellation Investments increased its Allergan plc (AGN) stake by 2.3% in Q1 2016, buying an estimated $57.3K and bringing the position to 8,840 shares worth $2.37M. The position accounts for 0.43% of the portfolio, ranked #54.

Constellation Investments first reported a position in AGN in Q2 2013 and has held it in 12 quarters since. The position peaked at $2.7M in Q4 2015. 1,119 funds tracked by Wall St. Rank hold AGN as of Q1 2016.

Constellation Investments held 8,840 shares of Allergan plc worth $2.37M as of Q1 2016.
Constellation Investments bought 200 Allergan plc shares in Q1 2016, an estimated $57.3K.
Allergan plc made up 0.43% of Constellation Investments's portfolio in Q1 2016, its #54 holding.
Constellation Investments first reported a position in Allergan plc in Q2 2013 and has held it in 12 quarters since.
Constellation Investments's Allergan plc position peaked at $2.7M in Q4 2015.
1,119 funds tracked by Wall St. Rank held Allergan plc as of Q1 2016.

Based on Constellation Investments's 13F filing for Q1 2016, filed 28 Apr 2016.